| Sep '20 | Jun '20 | Mar '20 | Dec '19 | Older periods | |
|---|---|---|---|---|---|
P/E ratio |
0.00 | 0.00 | 0.00 | 0.00 |
+8 more quarters Free account |
P/S ratio |
0.09 | 0.17 | 0.13 | 1.33 | |
P/FCF ratio |
0.00 | 0.00 | 0.00 | 0.00 | |
P/Operating CF |
(0.71) | (1.39) | (0.69) | (4.18) | |
P/B ratio |
0.02 | 0.04 | 0.03 | 0.29 | |
Price to Tangible BV |
0.02 | 0.04 | 0.03 | 0.29 | |
EV/Sales |
9.92 | 18.40 | 15.51 | 18.01 | |
EV/EBITDA |
0.00 | 0.00 | 0.00 | 0.00 | |
EV/Operating CF |
(12.01) | (44.85) | (40.15) | (61.61) | |
EV/FCF |
(11.15) | (36.37) | (32.40) | (40.46) | |
Quick Ratio |
0.20 | 4.46 | 3.99 | 4.16 | |
Current Ratio |
0.26 | 5.53 | 4.89 | 5.18 | |
Net Debt/EBITDA |
(60.54) | (28.09) | (356.95) | (3.09) | |
Debt/Assets |
53.38% | 52.72% | 49.97% | 47.58% | |
Debt/Equity |
1.32 | 1.24 | 1.12 | 1.00 | |
Asset Turnover |
0.09 | 0.09 | 0.10 | 0.09 | |
Operating CF/Net income |
0.36 | 0.30 | 0.77 | 0.24 | |
Capex/Depreciation |
(0.08) | (0.04) | (0.19) | (0.15) | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
18.28% | 27.90% | 10.78% | 24.70% | |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 | |
Share Based Compensation of Revenue |
2.99% | 4.64% | 2.07% | 6.02% | |
Graham Net Nets |
(51.94) | (24.34) | (25.79) | (2.60) | |
Graham Number |
0.00 | 0.00 | 0.00 | 0.00 | |
Earnings Yield |
(2,920.83%) | (1,487.76%) | (1,653.49%) | (181.86%) | |
Free Cash Flow Yield |
(1,024.85%) | (296.27%) | (375.13%) | (33.42%) | |
Revenue per Share |
0.62 | 0.52 | 1.19 | 0.44 | |
Operating CF per Share |
(0.34) | (0.35) | (0.62) | (0.98) | |
Capex per Share |
(0.03) | (0.01) | (0.08) | (0.05) | |
Free Cash Flow per Share |
(0.37) | (0.37) | (0.70) | (1.03) | |
Cash per Share |
2.99 | 3.36 | 3.73 | 3.80 | |
Shareholders Equity per Share |
11.37 | 12.29 | 13.43 | 14.25 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
11.37 | 12.29 | 13.43 | 14.25 | |
Free Cash Flow |
(27.63) | (27.51) | (52.68) | (77.15) | |
Working Capital |
(904.04) | 283.62 | 337.20 | 315.17 | |
Capital Expenditures |
(2.37) | (1.05) | (5.92) | (4.00) | |
Net Current Asset Value |
(937.47) | (896.86) | (833.69) | (797.14) | |
EV/EBIT |
0.00 | 0.00 | 0.00 | 0.00 | |
Capex to Sales |
0.05 | 0.03 | 0.07 | 0.12 | |
Net Profit Margin |
(151.34%) | (224.62%) | (68.17%) | (930.00%) | |
Price to Operating Income |
0.00 | 0.00 | 0.00 | 0.00 | |
| Other line items | |||||
Average Receivables |
26.96 | 60.24 | 70.26 | 48.90 | |
Average Payables |
14.26 | 18.44 | 18.54 | 19.58 | |
Average Inventory |
44.60 | 43.77 | 43.09 | 42.18 | |
Average Assets |
2,328.45 | 2,388.61 | 2,476.59 | 2,502.39 | |
Average Common Equity |
1,114.85 | 1,193.82 | 1,272.58 | 1,343.89 |
Columns are period end dates